Purchasers Seek Namenda Litigation Docs In Antitrust Suit

Law360, New York (April 13, 2017, 1:51 PM EDT) -- A proposed class of drug wholesalers accusing an Allergan PLC unit of antitrust violations asked a New York federal judge on Wednesday to force production of documents relating to the drugmaker's alleged attempts to prevent competition from generic versions of the Alzheimer’s treatment Namenda.

In a Wednesday motion to compel, the wholesalers, or direct purchasers, asked Forest Laboratories LLC to turn over documents relating to its pursuit of patent claims against generic companies vying to make an alternative to the Alzheimer’s drug. This comes as the...
To view the full article, register now.